Bosas, P.; Zaleskis, G.; Dabkevičiene, D.; Dobrovolskiene, N.; Mlynska, A.; Tikuišis, R.; Ulys, A.; Pašukoniene, V.; Jarmalaitė, S.; Jankevičius, F.
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients. J. Clin. Med. 2021, 10, 3709.
https://doi.org/10.3390/jcm10163709
AMA Style
Bosas P, Zaleskis G, Dabkevičiene D, Dobrovolskiene N, Mlynska A, Tikuišis R, Ulys A, Pašukoniene V, Jarmalaitė S, Jankevičius F.
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients. Journal of Clinical Medicine. 2021; 10(16):3709.
https://doi.org/10.3390/jcm10163709
Chicago/Turabian Style
Bosas, Paulius, Gintaras Zaleskis, Daiva Dabkevičiene, Neringa Dobrovolskiene, Agata Mlynska, Renatas Tikuišis, Albertas Ulys, Vita Pašukoniene, Sonata Jarmalaitė, and Feliksas Jankevičius.
2021. "Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients" Journal of Clinical Medicine 10, no. 16: 3709.
https://doi.org/10.3390/jcm10163709
APA Style
Bosas, P., Zaleskis, G., Dabkevičiene, D., Dobrovolskiene, N., Mlynska, A., Tikuišis, R., Ulys, A., Pašukoniene, V., Jarmalaitė, S., & Jankevičius, F.
(2021). Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients. Journal of Clinical Medicine, 10(16), 3709.
https://doi.org/10.3390/jcm10163709
